Sunovion is a global biopharmaceutical company focused on the application of science and medicine to help people with serious medical conditions. The Company has charted new paths to life-transforming treatments that reflect ongoing investments in research and development and an unwavering commitment to support people with psychiatric, neurological, and respiratory conditions. Sunovion’s track record of discovery, development, and commercialization of important therapies has included Brovana (arformoterol tartrate), Latuda (lurasidone HCI), and most recently Aptiom (eslicarbazepine acetate).

Type
Subsidiary
HQ
Marlborough, US
Founded
1984
Sunovion Pharmaceuticals was founded in 1984 and is headquartered in Marlborough, US
Report incorrect company information

Sunovion Pharmaceuticals Office Locations

Sunovion Pharmaceuticals has offices in Marlborough, Fort Lee and Mississauga
Marlborough, US (HQ)
84 Waterford Dr
Fort Lee, US
510 1 Bridge Plaza N
Mississauga, CA
100 6790 Century Ave
Show all (3)
Report incorrect company information

Sunovion Pharmaceuticals Financials and Metrics

Summary Metrics

Founding Date

1984

Investors

Report incorrect company information